Patents Examined by Amy L. Clark
  • Patent number: 10953067
    Abstract: An herbal composition, comprising a therapeutically effective amount of an extract of Terminalia chebula; a therapeutically effective amount of an extract of Curcuma longa; and a therapeutically effective amount of a non-acidic, water-immiscible organic solvent extract of a Boswellia serrata resin.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: March 23, 2021
    Assignee: LAILA NUTRACEUTICALS
    Inventors: Ganga Raju Gokaraju, Rama Raju Gokaraju, Venkata Kanaka Ranga Raju Gokaraju, Trimurtulu Golakati, Kiran Bhupathiraju, Venkata Krishna Raju Alluri, Krishanu Sengupta
  • Patent number: 10946058
    Abstract: Described herein are food additives prepared from the inner core of a banana plant stem, along with methods of making and using same.
    Type: Grant
    Filed: March 26, 2014
    Date of Patent: March 16, 2021
    Inventor: Uppala Rajakaruna
  • Patent number: 10947497
    Abstract: The present invention relates to Nelumbo nucifera callus having an increased content of gallic acid or an extract thereof and to a method for preparing the same. The Nelumbo nucifera callus extract according to the present invention has an excellent whitening effect by containing a large amount of gallic acid, and thus can be advantageously used as a cosmetic composition.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: March 16, 2021
    Assignees: Celltrion Inc., BIO-FD&C Co., Ltd.
    Inventors: Yeon Sook Kim, Jung Yeon Kim, Jae Hun Kim, Hyeong Mi Kim, Jung Soo Bae, Jung Yun Kim, Ju Yeon Kim, Joo Hyuck Lim, Seung Ki Lee, Sung Ho Moon, Shin Jae Chang, Sang Hyun Moh, Jeong Hun Lee, Hyo Hyun Seo, Ji Hong Moh, Soo Yun Kim, Jeong Gon Park
  • Patent number: 10940175
    Abstract: The invention relates to Boswellia frereana and particularly an extract of same for treating a range of inflammatory disorder or conditions selected from the group comprising: inflammatory bowel disease (IBD), all forms of muscular dystrophy especially Duchenne muscular dystrophy, sepsis, sepsis syndrome, osteoporosis, ischemic injury, graft vs. host disease, reperfusion injury, asthma, diabetes, cancer, myelogenous and other leukemias, psoriasis and cachexia, Alzheimer's Disease, demyelinating neurological disorders including multiple sclerosis, acetylcholinesterase mediated disorders, retinal disorders, neurological, retinal, and muscular disorders.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: March 9, 2021
    Assignee: COMPTON DEVELOPMENTS LTD.
    Inventors: Emma Jane Blain, Victor Collin Duance, Ahmed Yasine Ali, Ifor Delme Bowen
  • Patent number: 10925910
    Abstract: A novel treatment for topical inflammatory conditions such as acne, eczema, shingles, insect bites, and hives is provided, consisting of the application of a herbal cream or ointment which incorporates grounded PawPaw Seeds in a granular form. The cream preferably contains one or more thickeners, a bio-adhesive agent such as petroleum jelly such that the cream can stick to the area to be treated.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: February 23, 2021
    Inventor: Emmanuel Osei-Kumi
  • Patent number: 10905800
    Abstract: An ocular covering fabricated from at least one amniotic membrane, at least one chorionic membrane, or at least one amniotic membrane and at least one chorionic membrane obtained from human birth tissue is provided. Methods of preparing the one or more membranes to form an ocular covering are provided. Methods of treating a disease, condition, or surgical site of the eye and surrounding tissue are also provided.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: February 2, 2021
    Assignee: BioDlogics, LLC
    Inventor: Timothy R. Brahm
  • Patent number: 10905139
    Abstract: Disclosed is a beverage and a method of administering the beverage. The beverage is free of phosphoric acid and instead contains at least 0.3% by weight/volume of gluconic acid, is low in minerals, specifically contains less than 250 mg/liter of minerals, is low in sugar, specifically contains at most 2.5% by weight/volume of sugar. These sugars comprise at least 10% weight/weight galactose and in addition a proportion of isomaltulose and/or tagatose The beverage has a glycemic index of at most 35 (GI<35).
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: February 2, 2021
    Inventor: Johannes Coy
  • Patent number: 10898611
    Abstract: A bone implant comprising cancellous bone that is essentially free of blood cells, and which has been treated with at least one loosening agent, such as collagenase or a digestive enzyme, for a time and at a concentration to loosen the osteogenic cells in the cancellous bone matrix. The osteogenic cells in the matrix are viable cells. The treatment of the cancellous bone with at least one loosening agent enables the osteogenic cells to be more available for carrying out their osteogenic function and to provide for an increased rate of bone formation. Such implant also may include demineralized bone, such as demineralized cortical bone, which enhances the bone regenerative capacity of the cancellous bone.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 26, 2021
    Assignee: NuVasive, Inc.
    Inventors: Michelle LeRoux Williams, Charles Randal Mills, Rodney Monroy, Robert A. Zambon, Dayna Buskirk, Earl Fender
  • Patent number: 10894070
    Abstract: A pharmaceutical composition includes an alcohol-soluble, water insoluble, extract of Radix Glycyrrhizae; and wolfberry. A weight ration of the extract and wolfberry is 0.01˜5:15˜25. The composition is useful for controlling blood glucose and blood lipids, and for weight control. Health food products containing the recited combination are also provided.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: January 19, 2021
    Inventors: James Zhou, Dong Chen
  • Patent number: 10894072
    Abstract: Embodiments of the invention generally relate to supplements for treating fibromyalgia and symptoms associated with fibromyalgia, wherein the nutritional supplement is administered for at least one of following: fatigue, chronic pain, morning stiffness, headaches, and problems with thinking and memory.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: January 19, 2021
    Assignee: IP Quality Holdings, LLC
    Inventors: Amy L. Heaton, Dennis Gay
  • Patent number: 10881104
    Abstract: The present invention generally relates to compositions and methods related to controlling arthropods. Embodiments of the invention include compositions for controlling an arthropod, which can include one or more plant essential oils and methods for using these compositions. The plant essential oils, when combined, can have a synergistic effect. Embodiments of the invention relate to compositions and methods related to controlling lice.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: January 5, 2021
    Assignee: TYRATECH, INC.
    Inventors: Keith Kennedy, Jason Schmidt
  • Patent number: 10857193
    Abstract: Cactus pear (Opuntia) extract compositions, their methods of preparation, and their uses in products are provided. The Opuntia extract compositions are a mixture of an extract prepared by extraction of Opuntia fruit/fruit parts, combined with an extract prepared by extraction of Opuntia cladodes/cladode parts. The resulting Opuntia extract compositions exhibit improved therapeutic characteristics as compared with known Opuntia fruit juices or extracts, including increased hypoglycemic effects.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: December 8, 2020
    Assignee: FINZELBERG GMBH & CO. KG
    Inventors: Ivo Pischel, Bjoern Feistel, Bernd Walbroel
  • Patent number: 10849950
    Abstract: A composition for treating fatty liver which comprises extracts of ginseng, Atractylodes rhizome, Crataegus cuneate, Alisma tuber and Cassia obtusifolia L.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: December 1, 2020
    Inventor: Masanori Nasu
  • Patent number: 10849930
    Abstract: In particular, a composition for breast augmentation that includes a composition promoting an increase in subcutaneous tissue, wherein the promoting composition aims at accumulating and increasing adipose tissue under the skin of a breast by generating and increasing the adipose tissue around a mammary gland and enables recovery of autologous tissue and recovery of appearance by a safe and natural process, and a method for breast augmentation are provided. A composition promoting an increase in subcutaneous tissue that contains autologous plasma and a basic fibroblast growth factor (b-FGF), in particular, a composition for breast augmentation is provided. A composition for breast augmentation that includes the above-described composition promoting an increase in subcutaneous tissue that further contains fat is provided.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: December 1, 2020
    Inventor: Kensuke Yamakawa
  • Patent number: 10842827
    Abstract: There are disclosed an effective dosage of major royal jelly protein 1 for treating various skin ailments. Instead of administering royal jelly, an effective amount of the active constituent of royal jelly, MRJP1 is administered either alone or in combination with other topical pharmaceuticals.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: November 24, 2020
    Inventor: José Manuel Aguilar Yáñez
  • Patent number: 10842805
    Abstract: The invention relates to unique compositions containing enriched and purified natural crocin and/or crocetin for prevention and/or treatment of cancers and other conditions and diseases. Compositions comprise mainly enriched or purified natural crocin or crocetin or combination of both and possible other active phytochemicals. A composition is used as functional food, drink, dietary supplement, or therapeutic dosage to a human orally or through other appropriate way (parenteral, percutaneous, rectal, mucosal, intranasal or topical administration). A method of natural crocin and crocetin enriching and purification is revealed.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: November 24, 2020
    Inventor: Song Gao
  • Patent number: 10835540
    Abstract: The invention relates to the use of a pharmaceutical medication comprising an aromatase inhibitor, preferably a steroidal aromatase inactivator and an antioxidant as effective ingredients for the treatment of sex hormone-dependent diseases. Furthermore, the invention relates to a composition comprising an aromatase inhibitor/—inactivator and ?-lipoic acid and/or extract of green tea containing polyphenols. The combination of an aromatase inhibitor and—inactivator and ?-lipoic acid and/or extract of green tea containing polyphenols is particularly suitable for the treatment of sex hormone-dependent diseases as well as for the treatment of benign tumors such as e.g. lipomatoses as occurring in Madelung's disease.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: November 17, 2020
    Assignee: Lucolas-M.D. Ltd.
    Inventor: Alfred Schmidt
  • Patent number: 10834959
    Abstract: The disclosure describes methods for the purification of protein-enriched extracts to provide concentrates and isolates and methods for incorporation of such materials into products. The purification methods are adapted for removal of nicotine and may have other benefits, e.g., lightening the color of the protein-enriched extracts. The methods generally include treatment with peracetic acid or hydrogen peroxide and filtrations. A protein composition in the form of a concentrate or isolate is provided, the protein composition including RuBisCO, F2 fraction proteins, or combination thereof extracted from a plant of the Nicotiana species, wherein the protein composition is characterized by relatively low nicotine content.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: November 17, 2020
    Assignee: R.J. Reynolds Tobacco Company
    Inventors: Kyle Ford, John-Paul Mua, Nicholas Partain, Joshua D. Morton, Barry Bratcher
  • Patent number: 10821145
    Abstract: The present invention is based on a plurality of benefits from the extracts of mycelia of individual fungal species, and mixtures of species, to provide an armamentarium of defenses from multiple stressors in order to help bees survive a complex of symptoms collectively called colony collapse disorder (CCD). More particularly, the present invention utilizes specific concentrations of extracts from pure cultured mycelium from mushroom forming fungi to reduce harmful viruses in bees and to increase the longevity of bees.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: November 3, 2020
    Inventor: Paul E. Stamets
  • Patent number: 10821149
    Abstract: The present invention relates to the pharmaceutical field, particularly to a composition and the use thereof. The composition serves to lower uric acid through the combination of several traditional Chinese medicines of Smilacis glabra rhizoma, Cichorii herba, Plantaginis herba and Coicis semen. On the basis of the combination of the traditional Chinese medicines described above, the addition of Alismatis rhizoma is able to improve the effect of lowering uric acid more significantly. Further, on the basis of the combination of the traditional Chinese medicines described above, the addition of tuna was able to improve the effect of lowering uric acid more significantly. A comprehensive analysis of the experimental results described above indicates that the compositions provided in the present invention have a significant effect of lowering uric acid.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: November 3, 2020
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Bin Shi, Xiaolei Guo, Chung Wah Ma, Chuixin Qin, Zhen Luo, Wei Zhang